Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.26
-0.04 (-0.35%)
Mar 9, 2026, 3:26 PM EDT - Market open
Keros Therapeutics Employees
Keros Therapeutics had 78 employees as of December 31, 2025. The number of employees decreased by 91 or -53.85% compared to the previous year.
Employees
78
Change (1Y)
-91
Growth (1Y)
-53.85%
Revenue / Employee
$3,128,987
Profits / Employee
$1,115,564
Market Cap
222.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 220 |
| Protalix BioTherapeutics | 213 |
| Voyager Therapeutics | 172 |
| Cibus | 159 |
| MediWound | 111 |
| Alector | 103 |
| Camp4 Therapeutics | 55 |
| Sol-Gel Technologies | 34 |
KROS News
- 7 hours ago - Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference - GlobeNewsWire
- 7 hours ago - Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS - GlobeNewsWire
- 4 days ago - Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 10 days ago - Keros Therapeutics Appoints Charles Newton to its Board of Directors - GlobeNewsWire
- 18 days ago - Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences - GlobeNewsWire
- 3 months ago - Keros Therapeutics Announces Final Results of Tender Offer - GlobeNewsWire
- 3 months ago - Keros Therapeutics Announces Preliminary Results of Tender Offer - GlobeNewsWire
- 4 months ago - Keros Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire